• 
  Antonietta Vilella, Benedetto Romoli, Martina Bodria, Stéphanie Pons, Uwe Maskos, et al.. Evidence for a protective effect of the loss of α4-containing nicotinic acetylcholine receptors on Aβ-related neuropathology in Tg2576 mice. Frontiers in Neuroscience, 2023, 17, pp.1097857. ⟨10.3389/fnins.2023.1097857⟩. ⟨pasteur-04551505⟩
• 
  Célia Raïs, Daniela Gaspar Santos, Giulia Sansone, Stéphane Blanchard, Jean-Pierre Bourgeois, et al.. Functional maturation of human iPSC-derived pyramidal neurons in vivo is dependent on proximity with the host tissue. Frontiers in Cellular Neuroscience, 2023, 23 (17), pp.1259712. ⟨10.3389/fncel.2023.1259712⟩. ⟨pasteur-04511558⟩
• 
  Estelle Darrau, Elise Jacquemet, Stéphanie Pons, Laurène Schlick, Marios Zouridakis, et al.. Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation. Translational Psychiatry, 2024, 14 (1), pp.146. ⟨10.1038/s41398-024-02853-8⟩. ⟨pasteur-04511551⟩
• 
  Valérian Dormoy, Jeanne-Marie Perotin, Philippe Gosset, Uwe Maskos, Myriam Polette, et al.. Nicotinic receptors as SARS-CoV-2 spike co-receptors?. Medical Hypotheses, 2022, 158, pp.110741. ⟨10.1016/j.mehy.2021.110741⟩. ⟨pasteur-03509149⟩
• 
  Qimeng Li, Ákos Nemecz, Gabriel Aymé, Gabrielle Dejean de la Bâtie, Marie S Prevost, et al.. Generation of nanobodies acting as silent and positive allosteric modulators of the α7 nicotinic acetylcholine receptor. Cellular and Molecular Life Sciences, 2023, 80 (6), pp.164. ⟨10.1007/s00018-023-04779-8⟩. ⟨pasteur-04094165v2⟩

36

7